MYOM3 and Duchenne muscular dystrophy: This finding correlates with the trend seen in CK activity over the 18 month DE50-MD study period, and is supported by the fact that levels of MYOM3 in human DMD patient samples are also affected by age, with patients aged three to 10 years exhibiting concentrations five times higher on average than patients aged 12 to 20 years24.